查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1326027

全球体外诊断 (IVD) 质量控制市场

In Vitro Diagnostics (IVD) Quality Control
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 88 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球体外诊断 (IVD) 质量控制市场将达到 18 亿美元

随着 COVID-19 后商业环境的变化，全球体外诊断 (IVD) 质量控制市场预计到 2022 年将达到 16 亿美元，到 2030 年预计将达到 18 亿美元，预计年复合成长率2%。本报告分析的细分市场之一——临床化学，预计年复合成长率3%，到分析期结束时达到 6.076 亿美元。鑑于大流行后的持续復苏，未来八年免疫化学领域的复合年复合成长率修正为 1.2%。

美国市场预计为4.308亿美元，中国预计复合年增长率为6.4%

到 2022 年，美国体外诊断 (IVD) 质量控制市场预计将达到 4.308 亿美元。中国作为世界第二大经济体，预计到2030年市场规模将达到4.376亿美元，2022年至2030年的分析期间年复合成长率为6.4%。其他值得注意的地域市场包括日本和加拿大，预计 2022 年至 2030 年将分别增长 -1.2% 和 0.5%。在欧洲，德国的年复合成长率预计约为-0.2%。

受访企业示例

  • Abbott Laboratories
  • Becton, Dickinson And Company（BD）
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eurotrol BV
  • F. Hoffmann-La Roche Ltd.
  • Fortress Diagnostics Limited
  • Helena Biosciences Europe
  • Maine Molecular Quality Controls, Inc.
  • Merck KGaA
  • Omega Diagnostics Group Plc
  • Ortho Clinical Diagnostics
  • Randox Laboratories Ltd.
  • Seracare Life Sciences Inc.
  • Sero As
  • Siemens Ag
  • Sun Diagnostics, LLC.
  • Technopath Clinical Diagnostics
  • Thermo Fisher Scientific Inc.
  • Zeptometrix Corporation

目录

第1章调查方法

第2章执行摘要

  • 市场概况
  • 大公司
  • 市场趋势和促进因素
  • 全球市场预测

第3章市场分析

  • 我们
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 意大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳大利亚
  • 印度
  • 韩国
  • 亚太地区其他地区
  • 拉美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙特阿拉伯
  • 阿拉伯联合酋长国
  • 其他中东地区
  • 非洲

第4章竞争

简介目录
Product Code: MCP22020

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global In Vitro Diagnostics (IVD) Quality Control Market to Reach $1.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for In Vitro Diagnostics (IVD) Quality Control estimated at US$1.6 Billion in the year 2022, is projected to reach a revised size of US$1.8 Billion by 2030, growing at aCAGR of 2% over the period 2022-2030. Clinical Chemistry, one of the segments analyzed in the report, is projected to record 3% CAGR and reach US$607.6 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Immunochemistry segment is readjusted to a revised 1.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $430.8 Million, While China is Forecast to Grow at 6.4% CAGR

The In Vitro Diagnostics (IVD) Quality Control market in the U.S. is estimated at US$430.8 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$437.6 Million by the year 2030 trailing a CAGR of 6.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at -1.2% and 0.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately -0.2% CAGR.

Select Competitors (Total 32 Featured) -

  • Abbott Laboratories
  • Becton, Dickinson And Company (BD)
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Eurotrol B.V.
  • F. Hoffmann -La Roche Ltd.
  • Fortress Diagnostics Limited
  • Helena Biosciences Europe
  • Maine Molecular Quality Controls, Inc.
  • Merck KGaA
  • Omega Diagnostics Group Plc
  • Ortho Clinical Diagnostics
  • Randox Laboratories Ltd.
  • Seracare Life Sciences Inc.
  • Sero As
  • Siemens Ag
  • Sun Diagnostics, LLC.
  • Technopath Clinical Diagnostics
  • Thermo Fisher Scientific Inc.
  • Zeptometrix Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • In Vitro Diagnostics (IVD) Quality Control - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Immunochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Immunochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Immunochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Clinical Chemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Clinical Chemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Clinical Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Clinical Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 25: World In Vitro Diagnostics (IVD) Quality Control Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 31: USA 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: USA 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • JAPAN
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • CHINA
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: China Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: China 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: China Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: China 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • EUROPE
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • FRANCE
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: France Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: France 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: France Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: France 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • GERMANY
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: UK 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: UK 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • INDIA
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: India Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 121: India 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: India Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 124: India 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • MIDDLE EAST
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030
  • AFRICA
    • In Vitro Diagnostics (IVD) Quality Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for In Vitro Diagnostics (IVD) Quality Control by Application - Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by Application - Percentage Breakdown of Value Sales for Clinical Chemistry, Immunochemistry, Molecular Diagnostics, Hematology and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for In Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals, Clinical Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for In Vitro Diagnostics (IVD) Quality Control by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinical Laboratories and Other End-Uses for the Years 2014, 2023 & 2030

IV. COMPETITION